These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4599785)

  • 1. Nasopharyngeal carcinoma. IV. Evolution of complement-fixing antibodies during the course of the disease.
    De-Thé G; Sohier R; Ho JH; Freund R
    Int J Cancer; 1973 Sep; 12(2):368-77. PubMed ID: 4599785
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytotoxic antibodies to cultured lymphoblasts unrelated to Epstein-Barr virus.
    Yang CS; Hewetson JF
    Int J Cancer; 1974 Oct; 14(4):530-8. PubMed ID: 4376526
    [No Abstract]   [Full Text] [Related]  

  • 3. Specific neutralizing antibodies in Epstein-Barr virus associated diseases.
    Rocchi G; Hewetson J; Henle W
    Int J Cancer; 1973 May; 11(3):637-47. PubMed ID: 4364719
    [No Abstract]   [Full Text] [Related]  

  • 4. Epstein-Barr virus-associated antigens activated in human cells by 5-bromodeoxyuridine.
    Gerber P; Lucas S
    Proc Soc Exp Biol Med; 1972 Nov; 141(2):431-8. PubMed ID: 4344263
    [No Abstract]   [Full Text] [Related]  

  • 5. Increase in antibody titer against the EBV-associated membrane antigen complex in Burkitt's lymphoma and nasopharyngeal carcinoma after local irradiation.
    Einhorn N; Klein G; Clifford P
    Cancer; 1970 Nov; 26(5):1013-21. PubMed ID: 4920396
    [No Abstract]   [Full Text] [Related]  

  • 6. Herpes viruses and oncogenesis.
    Klein G
    Johns Hopkins Med J Suppl; 1974; 3():15-25. PubMed ID: 4370988
    [No Abstract]   [Full Text] [Related]  

  • 7. [Complement fixation with a soluble antigen: important differences of activity between the serums of Burkitt lymphoma, of rhinopharynx cancers and infectious mononucleosis].
    Sohier R; Thé G de-
    C R Acad Hebd Seances Acad Sci D; 1971 Jul; 273(1):121-4. PubMed ID: 4327134
    [No Abstract]   [Full Text] [Related]  

  • 8. Epstein-Barr virus infections.
    Middleton PJ
    Can Med Assoc J; 1974 Jan; 110(1):9-10. PubMed ID: 4358535
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of local radiotherapy on the level of EBV-associated membrane-reactive antibodies in the sera of patients with certain malignant tumors.
    Einhorn N
    Cancer; 1972 Mar; 29(3):714-23. PubMed ID: 4551307
    [No Abstract]   [Full Text] [Related]  

  • 10. Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients.
    Gunvén P; Klein G; Henle G; Henle W; Clifford P
    Nature; 1970 Dec; 228(5276):1053-6. PubMed ID: 4320656
    [No Abstract]   [Full Text] [Related]  

  • 11. The EB virus.
    Epstein MA; Achong BG
    Annu Rev Microbiol; 1973; 27():413-36. PubMed ID: 4356531
    [No Abstract]   [Full Text] [Related]  

  • 12. [Titer of antibodies against Burkitt's lymphoma virus in Burkitt's lymphoma and other diseases].
    Gunven P
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(9):228-32. PubMed ID: 4353758
    [No Abstract]   [Full Text] [Related]  

  • 13. EB virus in relation to tumours.
    Achong BG
    J Clin Pathol Suppl (R Coll Pathol); 1972; 6():51-7. PubMed ID: 4376155
    [No Abstract]   [Full Text] [Related]  

  • 14. Seroepidemiological studies on carcinoma of the nasopharynx.
    Lin TM; Yang CS; Chiou JF; Tu SM; Lin CC; Liu CH; Chen KP; Ito Y; Kawamura A; Hirayama T
    Cancer Res; 1973 Nov; 33(11):2603-8. PubMed ID: 4355974
    [No Abstract]   [Full Text] [Related]  

  • 15. Nasopharyngeal carcinoma. IX. Antibodies to EBNA and correlation with response to other ebv antigens in chinese patients.
    de-Thé G; Ho JH; Ablashi DV; Day NE; Macario AJ; Martin-Berthelon MC; Pearson G; Sohier R
    Int J Cancer; 1975 Nov; 16(5):713-21. PubMed ID: 171226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Epstein Barr virus antibody in nasopharyngeal carcinoma.
    Hsu MM; Chiou JF; McCabe BF
    Ann Otol Rhinol Laryngol; 1974; 83(1):19-25. PubMed ID: 4359674
    [No Abstract]   [Full Text] [Related]  

  • 17. Difference in heat stability of antigens associated with Epstein-Barr virus, demonstrated by immunodiffusion.
    Demissie A
    J Natl Cancer Inst; 1973 Sep; 51(3):751-60. PubMed ID: 4355217
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of EBV neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti-MA).
    de Schryver A; Klein G; Hewetson J; Rocchi G; Henle W; Henle G; Moss DJ; Pope JH
    Int J Cancer; 1974 Mar; 13(3):353-62. PubMed ID: 4362610
    [No Abstract]   [Full Text] [Related]  

  • 19. The EB virus in relation to infectious mononucleosis.
    Sutton RN
    J Clin Pathol Suppl (R Coll Pathol); 1972; 6():58-64. PubMed ID: 4376156
    [No Abstract]   [Full Text] [Related]  

  • 20. Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. I. Immunofluorescence.
    Ernberg I; Klein G; Kourilsky FM; Silvestre D
    J Natl Cancer Inst; 1974 Jul; 53(1):61-5. PubMed ID: 4365906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.